Extract

The main purpose of this study is to assess the seropersistence at yearly intervals from approximately 3 years (38 months) to 10 years (118 months) after the first booster vaccination (as applicable) with either FSME-IMMUN 0.25 ml Junior or FSME-IMMUN 0.5 ml by means of neutralization test (NT) (according to Adner et ak., 2001) and ELISA (IMMUNOZYM FSME Immunoglobulin G [IgG].

Inclusion criteria

• The main purpose of this study is to assess the seropersistence at yearly intervals from approximately 3 years (38 months) to 10 years (118 months) after the first booster vaccination (with either FSME-IMMUN 0.25 ml Junior or FSME-IMMUN 0.5 ml in Study 700401) in children, adolescents and young adults , and to assess the antibody response to a second booster vaccination with either FSME-IMMUN 0.25 ml Junior or FSME-IMMUN 0.5 ml administered in the present study

Links

• ictrp
• euctr
• euctr
• ictrp
• ictrp
• euctr